lobbying_activities: 2769978

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2769978	9b17da81-b39a-4ef7-8ae6-23a961f4245d	Q1	MUSCULAR DYSTROPHY ASSOCIATION, INC.	400348610	MUSCULAR DYSTROPHY ASSOCIATION, INC.	2022	first_quarter	PHA	Advocated for funding and implementation of the ACT for ALS, a law that should accelerate development of treatments for individuals with ALS and other neuromuscular diseases. Advocated for the passage of the Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act (H.R. 5030/S. 2706) Provided feedback and comments to the Senate's PREVENT Act.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE		100000	0	0	2022-04-05T14:19:01-04:00